newdrugapprovals.org
Reslizumab
Reslizumab (Cinqair®) Approved Active, FDA 2016-03-23 An interleukin-5 (IL-5) antagonist used to treat severe asthma. CAS 241473-69-8 Research Code CDP-835; CEP-38072; CTx-55700; SCH-5570; SCH-557…